🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this week's The New Yorker, I write about the nano-medicine and the "molecular machines" that could soon help treat cancer and infections. As one scientist put it, "We’re now at a place where we can influence the physics of the cell." newyorker.com/magazine/2024/…

As we get ready for the heat dome, worth reading Dhruv Khullar on what a heat wave actually does to your body. newyorker.com/news/annals-of…

I’m excited to announce that I’ll be in conversation with Atul Gawande at this year’s New Yorker Festival! We'll be talking about living longer and better, as individuals and as a society. Get your tickets here: nyer.cm/zCmbo30

Atul Gawande will teach us how to live longer and better, as individuals and as a society, in a conversation with the New Yorker contributing writer @dhruvkhullar. Tickets are sold out. Join our wait list here: newyorkerfest.visitlink.me/yycHxY

Meeting The Needs Of Socially Vulnerable Patients: Views Of ACO Leaders On Moving From Intent To Action By Dhruv Khullar Weill Cornell Medicine + coauthors. Read the full article: bit.ly/3SXOZRj

.Dhruv Khullar reports on how A.I. is transforming drug development, making it possible for scientists to identify and create potentially lifesaving new medicines at an accelerated rate. newyorker.com/magazine/2024/…

In this week's The New Yorker, I write about the ways that AI is starting to transform how we discover—and design—new drugs, and what it could mean for the future of medicine. newyorker.com/magazine/2024/…

Our new work on the patients and physicians who would be most affected by changes to Medicare telehealth policy Health Affairs:

In an article for Chief Healthcare Executive, Dhruv Khullar shares insight on the future of artificial intelligence in healthcare, and the importance of mitigating downsides while exploring opportunities: bit.ly/4dfqFBL

I'll be in conversation with Atul Gawande at The New Yorker Festival tomorrow, Oct 27th at 10 am. We'll cover health, longevity, A.I., CRISPR, his work at USAID, and other topics. If interested, you can tune in at the livestream below! New Yorker Festival newyorker.com/culture/new-yo…

An honor to share the stage with Atul Gawande New Yorker Festival. Our conversation is now up at the link below:

The skinny on ultra-processed foods newyorker.com/magazine/2024/… The New Yorker by Dhruv Khullar

.@dhruvkhullar reports on a burgeoning theory of nutrition that identifies ultra-processed foods as key culprits behind Americans’ uniquely poor health. nyer.cm/PJl2AQe

In this week’s The New Yorker, I write about a paradigm shift in nutrition science. What, exactly, are ultra-processed foods—and what, exactly, are they doing to our bodies?

In the The New Yorker Anniversary Issue, I write about what space travel does to the human body—and the scientists trying to figure out how to keep people healthy on a roundtrip journey to Mars... newyorker.com/magazine/2025/…

Enjoying joining hari sreenivasan Amanpour and Company for this wide-ranging conversation on ultra-processed foods, chronic disease, and the steps we can take toward healthier diets:

Please join us for the FASPE The MacLean Center joint symposium "Business and Medical Ethics: Ensuring the Primacy of Patient Care" featuring keynote speaker Dhruv Khullar - Saturday March 8th at the Gleacher Center in Chicago Registration link in the next post👇

Wonder and observation propelled not only Oliver Sacks’s writing but also his doctoring. “He studied how people adapted to their circumstances; he wanted to chronicle even when he couldn’t cure,” Dhruv Khullar reflects on the eclectic neurologist. nyer.cm/Q7jKmt4

Can A.I. find new uses for old drugs? Some scientists think that many lifesaving treatments could be hiding in plain sight—if only we knew where to look. My new piece in The New Yorker: newyorker.com/culture/open-q…